Scholars Central

Conference abstractPublished 16 Jul 2018

Medication without harm: Challenges and opportunities in advancing the global medication safety agenda

Authors: Oweikumo Eradiri

Colchester Hospital University NHS Foundation Trust, UK

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: Medicines are the most common healthcare intervention. However, the use of medicines is attendant with unsafe practices and errors, resulting in avoidable patient harm. Globally, medication incidents cost an estimated US$42 billion annually. To mitigate this, the World Health Organization (WHO), in March 2017, launched its third Global Patient Safety Challenge entitled Medication Without Harm, aiming to reduce the level of severe, avoidable harm related to medications by 50% over 5 years, globally. Medication errors arise from weak medication systems or human factors. Whereas safe systems have largely been implemented in developed countries, low- and Middle-Income Countries (LMIC) lack such systems. Patients living in LMICs suffer twice as many disability-adjusted life years lost due to medication-related harm, then those in highincome countries. Objective: This paper will explore the challenges and opportunities for improving medication safety using two case studies: United Kingdom and Nigeria. Methodology: The WHO Challenge has five objectives to: Assess harm and strengthen monitoring; create a framework for improvement action; develop guidance and tools for safer systems; engage key stakeholders to raise awareness of the problem; empower patients to engage in medication decisions. This talk aligns with the fourth objective. Effects of change: The WHO Challenge proposes actions based on four domains: Patients and the public; medicines; healthcare professionals; systems and practices of medication. This talk intends to galvanise healthcare professionals to embrace the challenge and become catalysts that undertake research in safety, co-create and implement innovative, simple and impactful solutions that ensure patients using medicines are safer, globally.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Clinical Trials.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Clinical Trials
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Oweikumo Eradiri”